Novartis Continues Alzheimer’s Drug Litigation, Consolidates Suits For Discovery

Law360, New York (September 14, 2005, 12:00 AM EDT) -- Two separate patent infringement lawsuits brought by Swiss drug maker Novartis against Sun Pharmaceuticals over the Alzheimer drug Exelon have been consolidated in a New York federal court.

Novartis first sued the Indian generic maker in August 2004 in U.S. District Court for the Northern District of Illinois, asserting one of its two patents for the Alzheimer’s drug. That suit was later transferred to the Southern District of New York.

In July 2005, Sun challenged the second patent, leading to an additional lawsuit. Earlier this month,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.